Recon: Sanofi to Acquire Synthrox for $2.5B While Merck Picks up ArQule for $2.7B - Regulatory Focus

Recon: Sanofi to Acquire Synthrox for $2.5B While Merck Picks up ArQule for $2.7B  Regulatory Focus